Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection

Promising new viral hepatitis data presented today at the International Liver CongressTM show that entry inhibitors --a new mechanism of action for drugs to treat viral hepatitis -- could provide the first new hepatitis B and hepatitis D treatments for many years.1,2

Read the whole article on Physorg

More from Physorg